Key result
Anti-inflammatory drugs play a key therapeutic role across pericarditis, myocarditis, and related inflammatory diseases.
Why the study?
Recent developments including new anti-inflammatory drugs, evidence-based medicine, and changing disease patterns have highlighted the role of anti-inflammatory drugs in treating cardiac inflammatory diseases such as pericarditis and myocarditis.
Anti-inflammatory drugs, particularly colchicine for pericarditis and targeted immunosuppression for myocarditis, play a crucial role in managing cardiac inflammatory diseases.
Answers are grounded in this paper and cite their sources.
Supports anti-inflammatory strategies in cardiac inflammation; leaves open need for RCTs to guide adoption.
Throughout the history of cardiology, physicians have attempted to treat cardiac inflammatory diseases in a multitude of different ways. In recent years, three major developments have confirmed the important role of antiinflammatory drugs in cardiology: the development of new, more powerful drugs, the advent of evidence-based medicine, and the decline of rheumatic disease in western countries. Thus, we aim to review the indications for anti-inflammatory drugs in pericarditis and myocarditis. The management of pericarditis has been improved following the publication of the European guidelines in 2004. Indeed, recent randomized controlled trials highlighted the role of colchicine to i) prevent and treat recurrences of acute pericarditis and ii) prevent post pericardiectomy syndrome and its complications. With regard to the management of myocarditis, significant advances have been made towards further understanding the mechanisms involved, and in the identification of its underlying causes (especially viral vs. autoimmune). In addition, cardiac MRI and endomyocardial biopsy are now used to detect rare etiologies of myocarditis, which may benefit from immunosuppressive therapy (giant cell and eosinophilic myocarditis, cardiac sarcoidosis). Although broad consensus has yet to be reached regarding the management of acute myocarditis, identifying viral vs. autoimmune myocarditis allows a tailored treatment using antiviral or immunosuppressive drugs.
No takes yet. Share an insight, caveat, or question.
Algalarrondo et al. (2013) conducted a review in Pericarditis and myocarditis. Anti-inflammatory drugs was evaluated. Anti-inflammatory drugs, including colchicine for pericarditis and tailored immunosuppressive therapies for myocarditis, play an important role in the management of cardiac inflammatory diseases.
Synapse has enriched 10 related papers. Consider them for comparative context: